4‐trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2‐hydroxy‐4‐trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor κB activation
- 1 March 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 126 (6) , 1359-1366
Abstract
The effect of two derivatives of salicylate, 2‐hydroxy‐4‐trifluoromethylbenzoic acid (HTB) and 2‐acetoxy‐4‐trifluoromethylbenzoic acid (triflusal), on the activation of NF‐κB elicited by tumour necrosis factor‐α (TNF‐α) on human umbilical vein endothelial cells (HUVEC) was tested. The expression of the mRNA of vascular cell adhesion molecule‐1 (VCAM‐1) was studied as an example of a gene the expression of which is regulated by NF‐κB. To extend these findings to other systems, the induction of nitric oxide synthase in rat adherent peritoneal macrophages was studied. Both HTB and triflusal were more potent than aspirin or salicylate as inhibitors of the nuclear translocation of NF‐κB. The calculation of the IC50 values showed ∼amp;2 mM for HTB, 4 mM for aspirin and >4 mM for salicylate. Comparison of the potency of these compounds on VCAM‐1 mRNA expression showed complete inhibition by both triflusal and HTB at a concentration of 4 mM whereas aspirin and salicylate produced only 36–43% inhibition at the same concentration. Inhibition of NF‐κB activation was also observed in rat peritoneal macrophages stimulated via their receptors for the Fc portion of the antibody molecule with IgG/ovalbumin immune complexes. This was accompanied by a dose‐dependent inhibition of nitrite production by the L‐arginine pathway via iNOS. IC50 values for this effect were 1.13±0.12 mM (triflusal), 1.84±0.34 (HTB), 6.08±1.53 mM (aspirin) and 9.16±1.9 mM (salicylate). These data indicate that the incorporation of a 4‐trifluoromethyl group to the salicylate molecule strongly enhances its inhibitory effect on NF‐κB activation, VCAM‐1 mRNA expression and iNOS induction, irrespective of the presence of the acetyl moiety involved in the inhibition of cyclo‐oxygenase. British Journal of Pharmacology (1999) 126, 1359–1366; doi:10.1038/sj.bjp.0702441Keywords
This publication has 42 references indexed in Scilit:
- The Anti–Inflammatory Drug Sodium Salicylate Inhibits Nitric Oxide Formation Induced by Interleukin–1β At A Translational Step, But Not At A Transcriptional Step, in HepatocytesHepatology, 1997
- The anti-inflammatory drug sodium salicylate inhibits nitric oxide formation induced by interleukin-1β at a translational step, but not at a transcriptional step, in hepatocytesHepatology, 1997
- Salicylate Is a Transcriptional Inhibitor of the Inducible Nitric Oxide Synthase in Cultured Cardiac FibroblastsJournal of Biological Chemistry, 1996
- Aspirin inhibits expression of the interleukin‐1β‐inducible group II phospholipase A2FEBS Letters, 1996
- Nonsteroidal Anti-inflammatory Drugs Inhibit Expression of the Inducible Nitric Oxide Synthase GeneBiochemical and Biophysical Research Communications, 1995
- Curcumin, an Anti-tumor Promoter and Anti-inflammatory Agent, Inhibits Induction of Nitric Oxide Synthase in Activated MacrophagesBiochemical and Biophysical Research Communications, 1995
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994
- Pharmacokinetics of triflusal and its main metabolite in rats and dogsEuropean Journal of Drug Metabolism and Pharmacokinetics, 1991
- Augmentation of human blood acetylsalicylate concentrations by the simultaneous administration of acetaminophen with aspirinToxicology and Applied Pharmacology, 1977
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976